Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07292870
NA

Biologicals in Management of Intra-Bony Defects

Sponsor: Universitaire Ziekenhuizen KU Leuven

View on ClinicalTrials.gov

Summary

The aim is of this study is to evaluate and compare the effects (clinical and radiological) of different biomaterials on the repair of bone defects around the teeth. When participating in this study, persons will be scheduled for local surgical intervention of the gums. Under local anaesthesia, the gums will be opened minimally to gain insight into the underlying bone defect. After the bone defect has been made completely free of inflammation, they will be randomly assigned to one of the groups below and the biomaterials for this group will be used to fill the defect around your teeth. The different biomaterials are artificial bone + amelogenin; artificial bone + hyaluronic acid; artificial bone + blood preparation (L-PRF) or blood preparation alone. Then the gums will be closed again with a suture and they will receive the necessary instructions regarding the procedure.

Official title: Evaluation of the Addition of Different Biologicals in the Surgical Treatment of Periodontal Intra-Bony Defects: A Randomised Controlled Clinical Trial.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-08-08

Completion Date

2027-12-31

Last Updated

2026-03-17

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

Minimally invasive surgical treatment of the intra-bony defects

A surgical procedure is performed under local anaesthesia in which one of the biomaterials will be used to fill the intra-bony defect.

BIOLOGICAL

Use of the xenograft Bio-Oss® Collagen during the surgery

The clinician will use Bio-Oss® Collagen as adjuvant in the surgical treatment of the intra-bony defects in conjunction with minimally invasive surgery

BIOLOGICAL

Use of enamel matrix derivative (Emdogain®)

The clinician will use Enamel matrix derivative (Emdogain®) as adjuvant in the surgical treatment of the intra-bony defects in conjunction with minimally invasive surgery.

BIOLOGICAL

Use of hyaluronic acid (REGENFAST®)

The clinician will use hyaluronic acid (REGENFAST®) as adjuvant in the surgical treatment of the intra-bony defects in conjunction with minimally invasive surgery

BIOLOGICAL

use of the blood derivative L-PRF (leukocyte and platelet rich fibrin)

The clinician will use L-PRF as adjuvant in the surgical treatment of the intra-bony defects in conjunction with minimally invasive surgery.

Locations (1)

UZLeuven, Campus St. Raphaël, Department Oral Health Sciences, Periodontology

Leuven, Vlaams Brabant, Belgium